Tyson named chair of Executive Leadership Council

Tuesday, January 31, 2012 07:51 AM

Bernard Tyson, president and COO of Kaiser Permanente, has been named chair of the Executive Leadership Council (ELC)—a preeminent organization composed of African-American senior executives from the nation's Fortune 500 corporations that recognizes the strengths, success, contributions and impact of African-American business leaders. His term runs through Dec. 31, 2013.

"As chair, my role is to harness the collective energy and intellect of the ELC for the benefit of corporate America," Tyson said. "We must continue our focus on increasing the presence of highly qualified, capable and competent African-Americans at the CEO level or one to two levels below and on the boards of publicly-traded companies."

Tyson has been recognized for his work both within and outside of health care. In 2010 he was named one of the 25 most influential African Americans in health care by Black Health magazine, and one of the top 25 minority executives in the nation by Modern Healthcare. He currently serves on the board of the American Heart Association and Occidental College in Los Angeles, and is engaged in many philanthropic and community-based events.

"Bernard is an extremely effective leader with a demonstrated track record of achievement through collaboration, inclusion and acceptance," said George C. Halvorson, chairman and CEO of Kaiser Permanente. "His methods have produced very powerful outcomes within Kaiser Permanente. I am certain he will bring the same spirit to the ELC."

Arnold W. Donald, president and CEO of the ELC, said, "Bernard has been a very active member [of ELC] for many years, and we look forward to benefiting from his knowledge, creativity and guidance as we advance our efforts to increase African-American leadership at the most senior levels and on the boards of America's largest corporations.”

Share:          
CWWeekly

May 21

Parexel consultant testifies on FDA biosimilars guidance

Global Telecom Testing checks ex-U.S. toll-free phone lines for multinational clinical trials

To read the full articles for this issue of CWWeekly, please click here for subscription information.

Already a digital subscriber? Access this issue now.

CWWeekly

May

Newer sites most optimistic about the future
Investigative sites of all sizes, from part-time physician-run sites to large dedicated research centers, report a rebound in operating conditions, according to a new CenterWatch analysis, yet sites from each subgroup indicate they have concerns…

Risk-based monitoring slow to catch on with industry
It's estimated that the cost of physically sending monitors to all investigative sites at regular intervals, a model the industry itself developed and has adhered to for about a decade, eats up one-third to one-half of…

Eye On Millennium
Millennium, The Takeda Oncology Company, discovers and develops novel treatments applying world-class recombinant technology to a wide variety of oncology disease targets…

To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.

Already a digital subscriber? Access this issue now.

JobWatch centerwatch.com/jobwatch

Featured Jobs